BACKGROUND: Inflammatory processes may play an important role in cognitive decline and dementia. We investigated the prospective association between levels of three markers of inflammation, plasma interleukin-6 (IL-6), serum C-reactive protein (CRP), serum amyloid A (SAA), and cognitive decline in an African-Caribbean community population. METHODS: Of 290 participants aged 55-75 years at baseline sampled from Primary Care registration lists in south London, 216 (75%) were re-interviewed after 3 years. Baseline plasma concentrations of IL-6, CRP and SAA were ascertained through immunoassays. A battery of psychometric tests was administered on both occasions and decline in both individual tests and a composite outcome was analysed. RESULTS: After adjustment for potential confounding factors, raised levels of IL-6 (>3.1 pg/ml) were associated with cognitive decline in the total sample (odds ratio 2.9, 95% CI 1.1-7.5), but no associations were found for CRP or SAA. Raised IL-6 was most strongly associated with decline in orientation and immediate verbal recall tasks, with weaker associations for delayed recall and psychomotor speed. CONCLUSIONS: Raised IL-6 but not CRP predicted cognitive decline in this population Inflammatory changes associated with cognitive decline may be specific to particular causal pathways. Copyright (c) 2007 John Wiley & Sons, Ltd.
BACKGROUND: Inflammatory processes may play an important role in cognitive decline and dementia. We investigated the prospective association between levels of three markers of inflammation, plasma interleukin-6 (IL-6), serum C-reactive protein (CRP), serum amyloid A (SAA), and cognitive decline in an African-Caribbean community population. METHODS: Of 290 participants aged 55-75 years at baseline sampled from Primary Care registration lists in south London, 216 (75%) were re-interviewed after 3 years. Baseline plasma concentrations of IL-6, CRP and SAA were ascertained through immunoassays. A battery of psychometric tests was administered on both occasions and decline in both individual tests and a composite outcome was analysed. RESULTS: After adjustment for potential confounding factors, raised levels of IL-6 (>3.1 pg/ml) were associated with cognitive decline in the total sample (odds ratio 2.9, 95% CI 1.1-7.5), but no associations were found for CRP or SAA. Raised IL-6 was most strongly associated with decline in orientation and immediate verbal recall tasks, with weaker associations for delayed recall and psychomotor speed. CONCLUSIONS: Raised IL-6 but not CRP predicted cognitive decline in this population Inflammatory changes associated with cognitive decline may be specific to particular causal pathways. Copyright (c) 2007 John Wiley & Sons, Ltd.
Authors: Julian N Trollor; Evelyn Smith; Emmeline Agars; Stacey A Kuan; Bernhard T Baune; Lesley Campbell; Katherine Samaras; John Crawford; Ora Lux; Nicole A Kochan; Henry Brodaty; Perminder Sachdev Journal: Age (Dordr) Date: 2011-08-19
Authors: May A Beydoun; Jordan Weiss; Hardeep K Obhi; Hind A Beydoun; Gregory A Dore; Hailun Liang; Michele K Evans; Alan B Zonderman Journal: Brain Behav Immun Date: 2019-04-11 Impact factor: 7.217
Authors: Kaancan Deniz; Charlotte C G Ho; Kimberly G Malphrus; Joseph S Reddy; Thuy Nguyen; Troy P Carnwath; Julia E Crook; John A Lucas; Neill R Graff-Radford; Minerva M Carrasquillo; Nilüfer Ertekin-Taner Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Robert Stewart; Robert J Weyant; Melissa E Garcia; Tamara Harris; Lenore J Launer; Suzanne Satterfield; Eleanor M Simonsick; Kristine Yaffe; Anne B Newman Journal: J Am Geriatr Soc Date: 2013-02 Impact factor: 5.562
Authors: Alexis Economos; Clinton B Wright; Yeseon Park Moon; Tatjana Rundek; Leroy Rabbani; Myunghee C Paik; Ralph L Sacco; Mitchell S V Elkind Journal: Neuroepidemiology Date: 2013-01-24 Impact factor: 3.282